TY - JOUR
T1 - Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2
AU - Verbakel, Jan Y.
AU - de Rop, Liselore
AU - Stegeman, Inge
AU - Holtman, Gea A.
AU - Ochodo, Eleanor A.
AU - Yang, Bada
AU - Guleid, Fatuma
AU - Cochrane COVID-19 Diagnostic Test Accuracy Group
AU - Davenport, Clare
AU - Deeks, Jonathan J.
AU - Dinnes, Jacqueline
AU - Dittrich, Sabine
AU - Emperador, Devy
AU - Hooft, Lotty
AU - Spijker, René
AU - van den Bruel, Ann
AU - Wang, Junfeng
AU - Takwoingi, Yemisi
AU - Langendam, Miranda W.
AU - Leeflang, Mariska M. G.
N1 - Funding Information:
Jonathan Deeks is a United Kingdom National Institute for Health Research (NIHR) Senior Investigator Emeritus. Yemisi Takwoingi is supported by a NIHR Postdoctoral Fellowship. Jonathan Deeks, Jacqueline Dinnes, Yemisi Takwoingi, and Clare Davenport are supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.
Funding Information:
The editorial base of the Cochrane Infectious Diseases Group is funded by UK aid from the UK government for the benefit of low-and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government’s official policies.
Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2021/9/17
Y1 - 2021/9/17
N2 - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. To assess the accuracy of routine blood-based laboratory tests to predict mortality and deterioration to severe or critical (from mild or moderate) COVID-19 in people with SARS-CoV-2 infection. Secondary objectives Where data are available, we will investigate whether prognostic accuracy varies according to a specific measurement or test, reference standard, timing of outcome verification, sample type, study design, and setting, including prevalence of the target condition (either by stratified analysis or meta-regression).
AB - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. To assess the accuracy of routine blood-based laboratory tests to predict mortality and deterioration to severe or critical (from mild or moderate) COVID-19 in people with SARS-CoV-2 infection. Secondary objectives Where data are available, we will investigate whether prognostic accuracy varies according to a specific measurement or test, reference standard, timing of outcome verification, sample type, study design, and setting, including prevalence of the target condition (either by stratified analysis or meta-regression).
UR - https://www.scopus.com/pages/publications/85116048350
U2 - 10.1002/14651858.CD015050
DO - 10.1002/14651858.CD015050
M3 - Article
SN - 1465-1858
VL - 2021
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 9
M1 - CD015050
ER -
SDG 3 Good Health and Well-being